国药现代(600420.SH)子公司获盐酸氢吗啡酮注射液药品注册证书
SHYNDECSHYNDEC(SH:600420) 智通财经网·2025-11-28 08:23

Core Viewpoint - The company, China National Pharmaceutical Group Modern (国药现代), announced that its wholly-owned subsidiary, China National Pharmaceutical Group Industrial Co., Ltd. (国药工业), has received the drug registration certificate for Hydromorphone Hydrochloride Injection from the National Medical Products Administration [1] Group 1 - The drug Hydromorphone, also known as Dihydromorphinone, is a semi-synthetic opioid alkaloid that has been in clinical use since 1926 [1] - Hydromorphone Hydrochloride Injection is indicated for patients requiring opioid analgesia [1]